End-of-day quote
Korea S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
17,650
KRW
|
+0.17%
|
|
+3.04%
|
+11.92%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
61,253
|
65,076
|
136,117
|
249,293
|
152,481
|
241,187
|
Enterprise Value (EV)
1 |
83,057
|
79,241
|
148,287
|
282,251
|
198,634
|
270,097
|
P/E ratio
|
10.4
x
|
6.52
x
|
10.5
x
|
12.7
x
|
17.8
x
|
19.4
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.27
x
|
0.32
x
|
0.65
x
|
0.93
x
|
0.64
x
|
1.14
x
|
EV / Revenue
|
0.37
x
|
0.39
x
|
0.71
x
|
1.05
x
|
0.83
x
|
1.27
x
|
EV / EBITDA
|
6.92
x
|
4.21
x
|
6.94
x
|
10.1
x
|
13.9
x
|
29.9
x
|
EV / FCF
|
253
x
|
8.15
x
|
-74.1
x
|
-12.3
x
|
-12.3
x
|
102
x
|
FCF Yield
|
0.4%
|
12.3%
|
-1.35%
|
-8.16%
|
-8.16%
|
0.98%
|
Price to Book
|
0.54
x
|
0.54
x
|
1.04
x
|
1.69
x
|
1
x
|
1.48
x
|
Nbr of stocks (in thousands)
|
15,294
|
15,294
|
15,294
|
15,294
|
15,294
|
15,294
|
Reference price
2 |
4,005
|
4,255
|
8,900
|
16,300
|
9,970
|
15,770
|
Announcement Date
|
3/1/19
|
2/29/20
|
3/1/21
|
3/1/22
|
3/1/23
|
2/29/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
223,214
|
204,695
|
208,255
|
268,797
|
239,433
|
212,396
|
EBITDA
1 |
11,995
|
18,830
|
21,352
|
27,893
|
14,276
|
9,025
|
EBIT
1 |
5,667
|
11,950
|
13,750
|
19,530
|
4,545
|
-2,428
|
Operating Margin
|
2.54%
|
5.84%
|
6.6%
|
7.27%
|
1.9%
|
-1.14%
|
Earnings before Tax (EBT)
1 |
7,112
|
13,463
|
15,865
|
24,284
|
8,203
|
12,580
|
Net income
1 |
5,872
|
9,978
|
12,986
|
19,696
|
8,571
|
12,399
|
Net margin
|
2.63%
|
4.87%
|
6.24%
|
7.33%
|
3.58%
|
5.84%
|
EPS
2 |
383.9
|
652.4
|
849.1
|
1,288
|
560.4
|
811.0
|
Free Cash Flow
1 |
328.2
|
9,721
|
-2,001
|
-23,033
|
-16,201
|
2,647
|
FCF margin
|
0.15%
|
4.75%
|
-0.96%
|
-8.57%
|
-6.77%
|
1.25%
|
FCF Conversion (EBITDA)
|
2.74%
|
51.63%
|
-
|
-
|
-
|
29.33%
|
FCF Conversion (Net income)
|
5.59%
|
97.43%
|
-
|
-
|
-
|
21.35%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/1/19
|
2/29/20
|
3/1/21
|
3/1/22
|
3/1/23
|
2/29/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
21,804
|
14,165
|
12,170
|
32,959
|
46,152
|
28,910
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.818
x
|
0.7522
x
|
0.57
x
|
1.182
x
|
3.233
x
|
3.204
x
|
Free Cash Flow
1 |
328
|
9,721
|
-2,001
|
-23,033
|
-16,201
|
2,647
|
ROE (net income / shareholders' equity)
|
5.32%
|
8.58%
|
10.3%
|
14.1%
|
4.97%
|
7.83%
|
ROA (Net income/ Total Assets)
|
2.16%
|
4.58%
|
5.13%
|
6.29%
|
1.28%
|
-0.66%
|
Assets
1 |
271,708
|
217,663
|
252,908
|
313,305
|
667,437
|
-1,891,278
|
Book Value Per Share
2 |
7,351
|
7,864
|
8,556
|
9,658
|
9,977
|
10,645
|
Cash Flow per Share
2 |
112.0
|
225.0
|
176.0
|
242.0
|
167.0
|
799.0
|
Capex
1 |
8,892
|
7,068
|
19,274
|
18,955
|
26,924
|
13,274
|
Capex / Sales
|
3.98%
|
3.45%
|
9.25%
|
7.05%
|
11.25%
|
6.25%
|
Announcement Date
|
3/1/19
|
2/29/20
|
3/1/21
|
3/1/22
|
3/1/23
|
2/29/24
|
|
1st Jan change
|
Capi.
|
---|
| +11.92% | 196M | | +11.47% | 63.22B | | -3.47% | 46.34B | | +13.72% | 39.97B | | +17.83% | 25.46B | | +7.27% | 18.68B | | -0.57% | 17.24B | | -21.73% | 15.81B | | +0.22% | 14.9B | | -19.10% | 13.74B |
Other Specialty Chemicals
|